您的当前位置:首页 > 行业数据 > 图17.度普利尤单抗的不良反应发生率整体与安慰剂类似
图片属性
图片格式:PNG 图片大小:183KB 图片尺寸:1771*829
同报告图片
 / 4
图17.度普利尤单抗的不良反应发生率整体与安慰剂类似_第1页
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
图17.度普利尤单抗的不良反应发生率整体与安慰剂类似_第2页
图17.度普利尤单抗的不良反应发生率整体与安慰剂类似_第3页
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
图17.度普利尤单抗的不良反应发生率整体与安慰剂类似_第4页
5oqx5q2J77yM5oiR5peg5rOV5o+Q5Y+W5Zu+54mH5Lit55qE5pWw5o2u5bm255Sf5oiQ6KGo5qC844CC
图17.度普利尤单抗的不良反应发生率整体与安慰剂类似_第5页
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
所属报告: 医药生物行业疾病治疗专题研究~COPD领域出现新突破:COPD治疗出现突破机遇风险并存-250213(25页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠